ストックスクリーナーアプリを入手
25.62
0.90%
0.2292
アフターアワーズ：
25.62
-0.0006
-0.00%
前日終値:
$25.39
開ける：
$25.2435
24時間の取引高:
2,918
Relative Volume:
0.21
時価総額：
$N/A
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+2.03%
1か月 パフォーマンス:
-4.72%
6か月 パフォーマンス:
-1.04%
1年 パフォーマンス:
-10.79%
1日の値動き範囲:
$25.24
$25.62
1週間の範囲:
$25.05
$25.98
52週間の値動き範囲:
$20.01
$29.21
Roundhill Glp 1 Weight Loss Etf Stock (OZEM) Company Profile
OZEM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OZEM
Roundhill Glp 1 Weight Loss Etf
|
25.62 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
318.09 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
645.16 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
648.26 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
251.45 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
572.61 | 124.43B | 0 | 0 | 0 | 0.00 |
Roundhill Glp 1 Weight Loss Etf (OZEM) 最新ニュース
NVO Wins FDA Approval for MASH Treatment: ETFs Likely to Gain - sg.finance.yahoo.com
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data - MSN
Investing in the Dip: Evaluating ETF Exposure to Eli Lilly Amid Sector Volatility and GLP-1 Growth - AInvest
Will drop go up or down throughout this week - AInvest
Novo Nordisk Shares Plunge, Drag Down Weight-Loss-Drug ETFs - ETF.com
How to Invest in GLP-1 Stocks - The Motley Fool
Weight-Loss Drug ETFs Generate Skinnier Returns Than Expected - The Daily Upside
ETFs to Capitalize on the Novo Nordisk-Septerna Deal - MSN
The GLP-1 Boom: Why OZEM is Poised to Capitalize on the Obesity Drug Revolution - AInvest
Inside Last Week's Wall Street Rally & Best-Performing ETF Areas - TradingView
5 Sector ETFs Up 10% Despite February's Market Slump - TradingView
Slower flows, small-cap woes, SEC nos! What to expect from ETFs in 2025 - Citywire
New Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFs - ETF Trends
Roundhill Investments Surpasses $4 Billion AUM Milestone – Company Announcement - Financial Times
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip - Yahoo Finance
Disruptive Theme of the Week: 2024's Top Investment Themes & Trends - ETF Trends
Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends
Tap the Weight-Loss Drug Market With These ETFs - Yahoo Finance
Ozempic and Weight Loss Drug ETFs Back in Spotlight After Key Earnings Results - Trackinsight
5 ETFs to Make the Most of Eli Lilly's Strength - Yahoo Finance
ETFs in Focus as Competition Heats Up in Weight Loss Drug Segment - Nasdaq
Where to Invest in Health Trends - Bloomberg.com
Top Themes in the First Half of 2024: Crypto, Chips, Ships & Silver - ETF Trends
Novo-Nordisk's "miracle weight-loss drug" has been approved domestically, waiting to explode onto the multi-billion dollar market! How to capture this wave of "weight-loss fever"? - 富途牛牛
Why Investors Haven't Feasted on Two New Weight-Loss ETFs - Investopedia
Weight-loss ETFs demand some heavy thinking - Financial Times
Wall Street issuer creates “Lucky 8” Chinese giant ETF to target the “Seven Heroes” of US stock technology - 富途牛牛
New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk - TradingView
OZEM, Weight Loss Drug ETFs: Should You Invest? - ETF.com
Did South Park mark the top for weight-loss stocks? - Sherwood News
OZEM ETF: 7 Things to Know About the New Roundhill GLP-1 & Weight Loss ETF - InvestorPlace
This new weight loss drug ETF bets big on two of the industry's leading players - CNBC
This Week in ETFs: Roster of 17 New ETFs Includes 6 Buffer Funds - ETF Trends
South Park Took On Crypto, AI Previously: Animated Comedy Targets Weight-Loss Drug Ozempic Next - Benzinga
Play These New ETFs to Tap Lucrative Weight Loss Drug Market - Yahoo Finance
Roundhill Investments Launches GLP-1 & Weight Loss ETF (OZEM) - Stock Titan
Fund Files: Eaton Vance, Voya PMs to depart; Roundhill launches active weight loss ETF - Citywire
Roundhill names new CEO - Citywire Professional Buyer
CHAT Stock Price | Roundhill Generative AI & Technology ETF - Investing.com
Roundhill Glp 1 Weight Loss Etf (OZEM) 財務データ
Roundhill Glp 1 Weight Loss Etf (OZEM) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.26%
0.11%
大文字化:
|
ボリューム (24 時間):